Search
Skip to Search Results- 2Jurasz, P.
- 2Moncada de la Rosa, C.
- 2Radziwon-Balicka, A.
- 1Brandwein, Joseph
- 1Fernandes, Bruna
- 1Ramer, C.
-
Angiostatin inhibits endothelial MMP-2 and MMP-14 expression: A hypoxia specific mechanism of action
Download2013
Zielnik-Drabik, B., Jurasz, P., Radziwon-Balicka, A., Moncada de la Rosa, C., Ramer, C.
Angiostatin is an angiogenesis inhibitor in part generated by and released from platelets. Since platelets upon thrombus formation can give rise to areas of hypoxia, we investigated the effects of angiostatin on endothelial cell migration and apoptosis during hypoxia. Human microvascular...
-
Incidence of Catheter-Related VTE in Acute Leukemia Patients Requiring Peripherally-Inserted Central Catheter
Download2015-05-21
Resident research day for Core Internal Medicine. Background- Central venous catheters (CVCs) are a leading cause of upper extremity deep vein thrombosis (UE DVT). Long term CVCs are required for chemotherapy in acute leukemia (AL), who can be thrombocytopenic which makes anticoagulation for CVC...
-
2012
Radziwon-Balicka, A., Jurasz, P., Moncada de la Rosa, C.
Platelets, in addition to maintaining hemostasis, also stimulate angiogenesis by generating and releasing, upon activation, factors that promote the growth of new blood vessels. To date, at least 20 angiogenesis-regulating factors have been identified in platelets, including both promoters and...